0001104659-21-084552.txt : 20210623 0001104659-21-084552.hdr.sgml : 20210623 20210623141356 ACCESSION NUMBER: 0001104659-21-084552 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20210623 DATE AS OF CHANGE: 20210623 EFFECTIVENESS DATE: 20210623 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Intrommune Therapeutics, Inc. CENTRAL INDEX KEY: 0001736977 IRS NUMBER: 364782195 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-403944 FILM NUMBER: 211038407 BUSINESS ADDRESS: STREET 1: 20 WEST 125TH ST STREET 2: SUITE 1 CITY: NEW YORK STATE: NY ZIP: 10027 BUSINESS PHONE: 6464948432 MAIL ADDRESS: STREET 1: 20 WEST 125TH STREET STREET 2: SUITE#1 CITY: NEW YORK STATE: NY ZIP: 10027 FORMER COMPANY: FORMER CONFORMED NAME: ZENII, LLC DATE OF NAME CHANGE: 20180410 D 1 primary_doc.xml X0708 D LIVE 0001736977 Intrommune Therapeutics, Inc. 20 W 125TH ST. UNIT #1 NEW YORK NY NEW YORK 10027 6464948432 DELAWARE ZENII LLC ZENII, LLC Corporation true 2021 Nelson Michael 20 W 125th St. Unit #1 New York NY NEW YORK 10027 Executive Officer Director William Reisacher 20 W 125th St. Unit #1 New York NY NEW YORK 10027 Director Erick Berglund 20 W 125th St. Unit #1 New York NY NEW YORK 10027 Director Biotechnology No Revenues 06c false true false true false 5000 20000000 0 20000000 false 0 0 0 0 true Intrommune Therapeutics, Inc. /s/ Michael Nelson Michael Nelson President 2021-06-22